MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.parkreldis.2024.106969

Медицинская библиотека · Parkinsonism & related disorders · 2024

Influence of anosognosia on patient-reported outcomes for psychiatric symptoms and quality of life in Huntington's disease.

Isaacs David A, Hay Kaitlyn R, Hoadley Jennifer, McDonell Katherine E, Brown Amy E, Wynn Amy, Claassen Daniel O, Gibson Jessie

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Anosognosia, defined as reduced awareness of one's deficit or symptom, is common in Huntington's disease (HD) and detectable at each disease stage. The impact of anosognosia on self-reporting in HD populations is critical to understand given growing use of patient-reported outcomes in HD clinical care and research. We aimed to determine the influence of anosognosia on patient-reported outcome measures assessing psychiatric symptoms and quality of life in HD.

METHODS

We enrolled HD patients to complete a battery of patient-reported and rater-administered measures, including the Anosognosia Scale, at baseline and 6 months later. Patient-reported outcome measures included NeuroQoL short forms for depression, anxiety, satisfaction with social roles and activities, and positive affect and well-being and Patient-Reported Outcomes Measurement Information System short forms for emotional distress-anger and sleep-related impairment. Anosognosia Scale-Difference Score indexed patient-clinician agreement on patient motor, cognitive, and behavioral abilities. We conducted multivariable linear regression analyses to quantify the association of baseline anosognosia with 6-month patient-reported outcomes.

RESULTS

Of 79 patients with complete Anosognosia Scale data at baseline, 25 (31.6 %) met the scale's criterion for anosognosia. In the regression analyses, baseline Difference Score improved prediction of 6-month patient-reported outcomes for depression, anxiety, anger, and positive affect and well-being (χ2(1) value range for likelihood ratio tests contrasting models with and without Difference Score: 13.1-20.9, p-values <0.001). Patients with more anosognosia self-reported less severe psychiatric symptoms and more positive affect and well-being.

CONCLUSION

Study results suggest that anosognosia influences patient-reported outcomes for psychiatric symptoms and quality of life in HD populations.

Для цитирования: Isaacs David A, Hay Kaitlyn R, Hoadley Jennifer, McDonell Katherine E, Brown Amy E, Wynn Amy, Claassen Daniel O, Gibson Jessie. Influence of anosognosia on patient-reported outcomes for psychiatric symptoms and quality of life in Huntington's disease.. Parkinsonism & related disorders. 2024. DOI: 10.1016/j.parkreldis.2024.106969.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.